124 Iodine: a longer-life positron emitter isotope-new opportunities in molecular imaging.
Giuseppe Lucio CasciniArtor Niccoli AsabellaAntonio NotaristefanoAntonino RestucciaCristina FerrariDomenico RubiniCorinna AltiniGiuseppe RubiniPublished in: BioMed research international (2014)
(124)Iodine ((124)I) with its 4.2 d half-life is particularly attractive for in vivo detection and quantification of longer-term biological and physiological processes; the long half-life of (124)I is especially suited for prolonged time in vivo studies of high molecular weight compounds uptake. Numerous small molecules and larger compounds like proteins and antibodies have been successfully labeled with (124)I. Advances in radionuclide production allow the effective availability of sufficient quantities of (124)I on small biomedical cyclotrons for molecular imaging purposes. Radioiodination chemistry with (124)I relies on well-established radioiodine labeling methods, which consists mainly in nucleophilic and electrophilic substitution reactions. The physical characteristics of (124)I permit taking advantages of the higher PET image quality. The availability of new molecules that may be targeted with (124)I represents one of the more interesting reasons for the attention in nuclear medicine. We aim to discuss all iodine radioisotopes application focusing on (124)I, which seems to be the most promising for its half-life, radiation emissions, and stability, allowing several applications in oncological and nononcological fields.
Keyphrases
- image quality
- dual energy
- computed tomography
- preterm infants
- physical activity
- working memory
- mental health
- prostate cancer
- cancer therapy
- radiation therapy
- positron emission tomography
- rectal cancer
- pet imaging
- mass spectrometry
- high resolution
- quantum dots
- anaerobic digestion
- real time pcr
- tandem mass spectrometry